Jun 18, 2020
Arena Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Jun 17, 2020
Scientific Games Announces Proposed Private Offering of $350.0 Million of Senior Unsecured Notes
Jun 16, 2020
Neenah Announces Refinancing Plans and Q2 Update
Jun 11, 2020
BRK Announces Filing of Substantial New Litigation Seeking USD$38.99 Million
Jun 09, 2020
Jazz Pharmaceuticals Announces Pricing of Private Offering of $850 Million of 2.000% Exchangeable Senior Notes due 2026
Jun 08, 2020
Jazz Pharmaceuticals Announces Private Offering of $850 Million of Exchangeable Senior Notes due 2026
May 20, 2020
Arena Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
May 11, 2020
CNS Provides Additional Comments Regarding Trading Halt
Apr 24, 2020
Arena Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Apr 23, 2020
Waste Connections Announces Regular Quarterly Cash Dividend
Apr 16, 2020
NeuroBo Pharmaceuticals Announces Closing of $7.5 Million Registered Direct Offering
Apr 15, 2020
CNS Pharmaceuticals Announces Shareholder Webinar to Discuss Collaboration with WPD Pharmaceuticals for Developing Coronavirus Drug Candidates, the Significance of WP1244, and an Update on the Cancer Free Survivor Treated with Berubicin
Apr 09, 2020
IPALCO Enterprises, Inc. Announces Proposed Private Offering of Senior Secured Notes
Mar 27, 2020
Huntington Ingalls Industries Announces Pricing of 3.844% Senior Notes Due 2025 and 4.200% Senior Notes Due 2030
Mar 26, 2020
Huntington Ingalls Industries Announces Proposed Offering of Senior Notes
Mar 24, 2020
OPKO Health's BioReference Laboratories and City of Miami Provide Testing for Coronavirus Disease 2019 (COVID-19)
Mar 23, 2020
OPKO Health's BioReference Laboratories and City of Detroit Provide Testing for Coronavirus Disease 2019 (COVID-19)
Mar 17, 2020
SunCoke Energy, Inc. Announces Board Refreshment And Succession Actions
Mar 09, 2020
Certain Algonquin Power & Utilities Corp. Senior Executives Establish Automatic Securities Disposition Plans
Mar 05, 2020
OPKO Health's BioReference Laboratories to Introduce Coronavirus Disease (COVID-19) Test